Cardiovascular Risk Reduction in Rheumatoid Arthritis With Diabetes
Abatacept may confer a reduction in CV risk in patients with rheumatoid arthritis, particularly if they also have diabetes.
PLWHIV who have received treatment had lower whole-brain standardized uptake values compared to healthy controls with risk for CVD as the best predictor.
There is an urgent need for blood and platelet donations in the United States because donations during September and October fell 21,000 units short of hospital needs.
For patients with prediabetes who are randomly assigned to interventions, changes in risk indicators of metabolic syndrome (MetS) severity are associated with the risk for T2DM.